Predictive Oncology (FRA:S1K) Operating Cash Flow per Share : €-3.03 (TTM As of Mar. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Predictive Oncology Operating Cash Flow per Share?

Predictive Oncology's operating cash flow per share for the three months ended in Mar. 2024 was €-0.78. Predictive Oncology's operating cash flow per share for the trailing twelve months (TTM) ended in Mar. 2024 was €-3.03.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 45.70% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 52.90% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 56.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Predictive Oncology's Operating Cash Flow per Share or its related term are showing as below:

FRA:S1K' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: 42.1 Med: 59.3 Max: 77.7
Current: 45.7

During the past 13 years, Predictive Oncology's highest 3-Year average Operating Cash Flow per Share Growth Rate was 77.70% per year. The lowest was 42.10% per year. And the median was 59.30% per year.

FRA:S1K's 3-Year OCF Growth Rate is ranked better than
91.87% of 689 companies
in the Medical Devices & Instruments industry
Industry Median: 2.9 vs FRA:S1K: 45.70

Predictive Oncology Operating Cash Flow per Share Historical Data

The historical data trend for Predictive Oncology's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Predictive Oncology Operating Cash Flow per Share Chart

Predictive Oncology Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Operating Cash Flow per Share

Get a 7-Day Free Trial

-54.58

-16.85

-3.94

-3.20

-3.07

Predictive Oncology Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Operating Cash Flow per Share	Get a 7-Day Free Trial															-0.81	-0.83	-0.72	-0.70	-0.78

Competitive Comparison of Predictive Oncology's Operating Cash Flow per Share

For the Medical Instruments & Supplies subindustry, Predictive Oncology's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Predictive Oncology's Price-to-Operating-Cash-Flow Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Predictive Oncology's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Predictive Oncology's Price-to-Operating-Cash-Flow falls into.

Predictive Oncology Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Predictive Oncology's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (A: Dec. 2023 )	=	Cash Flow from Operations (A: Dec. 2023 )	/	Shares Outstanding (Diluted Average) (A: Dec. 2023 )
	=	-12.094	/	3.93814
	=	-3.07

Predictive Oncology's Operating Cash Flow per Share for the quarter that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (Q: Mar. 2024 )	=	Cash Flow from Operations (Q: Mar. 2024 )	/	Shares Outstanding (Diluted Average) (Q: Mar. 2024 )
	=	-3.143	/	4.03329
	=	-0.78

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-3.03

Predictive Oncology Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Predictive Oncology's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Predictive Oncology (FRA:S1K) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Predictive Oncology Inc (FRA:S1K) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

POAI:USA

Address

2915 Commers Drive, Suite 900, Eagan, MN, USA, 55121

Website

https://www.predictive-oncology.com

Predictive Oncology Inc functions in the healthcare domain. The firm's reportable segments are Helomics, zPREDICTA, Soluble and Skyline. It derives prime revenue from the Skyline segment which consists of the STREAMWAY System product sales, and TumorGenesis subsidiary (Research and Development) is included within corporate. The STREAMWAY System virtually eliminates staff exposure to blood, irrigation fluid, and other potentially infectious fluids found in the healthcare environment. Its Helomics division is focused on improving the effectiveness of cancer therapy using proprietary, multi-omic tumor profiling platform, a one-of-a-kind database of historical tumor data, and the power of AI to build predictive models of tumor drug response.

Predictive Oncology (FRA:S1K) Headlines

No Headlines